Login / Signup

Impact of sodium-glucose cotransporter-2 inhibitors on heart failure and mortality in patients with cancer.

Cho-Han ChiangCho-Hung ChiangCho-Hsien ChiangKevin Sheng-Kai MaChun-Yu PengYuan Ping HsiaChuan-Sheng HorngCheng-Ying ChenYu-Cheng ChangXin Ya SeeYuan-Jen ChenShih-Syuan WangGiselle A Suero-AbreuL R PetersonPaaladinesh ThavendiranathanPhilippe ArmandCheng-Ming PengHer-Shyong ShiahTomas G Neilan
Published in: Heart (British Cardiac Society) (2022)
The use of SGLT2i was associated with a lower rate of incident HF and prolonged overall survival in patients with cancer with diabetes mellitus.
Keyphrases
  • heart failure
  • acute heart failure
  • cardiovascular events
  • cardiovascular disease
  • free survival
  • risk factors
  • glycemic control
  • atrial fibrillation
  • cardiac resynchronization therapy
  • type diabetes
  • skeletal muscle